Literature DB >> 7593445

Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study.

C A Jaffe1, D K Turgeon, R D Friberg, P B Watkins, A L Barkan.   

Abstract

Pulsatile GH secretion in humans is under the dual and opposing regulation of hypothalamic GHRH and SRIH. GH pulses result from acute GHRH secretory discharges, and their occurrence and amplitude are augmented at night. We hypothesized that normal adults have predictable circadian or ultradian patterns of SRIH secretion and that this rhythm modulates both spontaneous GH secretion and the GH response to GHRH in a similar manner. To test this hypothesis, we compared baseline GH concentration patterns with GH profiles during submaximal iv boluses of GHRH. Every 20 min blood sampling for plasma GH determination over a 24-h period was performed in seven middle-aged men on days 1 and 7. Each subject received a GHRH (0.33 microgram/kg) iv bolus every 2 h on days 2-7, during which the GH responses to the first two boluses were measured. Plasma insulin-like growth factor I (IGF-I) was measured at 0800 h on each day. [The subjects had GH response to every GHRH bolus] and the integrated GH concentration on day 7 was increased 4.3 +/- 0.6-fold over that in the baseline study on day 1. There was no acute or chronic desensitization to GHRH, and the pituitary remained equally responsive to the GHRH boluses despite a 2.6-fold increase in IGF-I by day 7. During this same time period, there was a 1.4-fold increase in IGF-binding protein 3. The subjects showed similar circadian patterns of GH secretion at baseline and during repetitive GHRH boluses, with a maxima on each day occurring during the early night-time hours. These data demonstrate that healthy men remain sensitive to the GH-releasing effects of submaximal bolus doses of GHRH despite significant increases in GH and IGF-I. The similarities between the GH concentration profiles during days 1 and 7 are consistent with the hypothesis that the ultradian pattern of GH secretion in humans is in part a product of hypothalamic GHRH discharges superimposed on more slowly changing SRIH secretion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7593445     DOI: 10.1210/jcem.80.11.7593445

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

Review 1.  Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.

Authors:  Monica Gola; Mauro Doga; Stefania Bonadonna; Gherardo Mazziotti; Pier Paolo Vescovi; Andrea Giustina
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

Review 2.  Reevaluation of conventional pituitary irradiation in the therapy of acromegaly.

Authors:  C A Jaffe
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

3.  Complex rhythmicity of growth hormone secretion in humans.

Authors:  Sowmya Surya; Kathleen Symons; Edward Rothman; Ariel L Barkan
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

4.  Regulatory mechanisms of growth hormone secretion are sexually dimorphic.

Authors:  C A Jaffe; B Ocampo-Lim; W Guo; K Krueger; I Sugahara; R DeMott-Friberg; M Bermann; A L Barkan
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

5.  The effect of exercise duration and mode on the growth hormone responses in young women on oral contraceptives.

Authors:  Lynn M Sauro; Jill A Kanaley
Journal:  Eur J Appl Physiol       Date:  2003-06-14       Impact factor: 3.078

Review 6.  Mechanisms underlying the neuroendocrine response to physical exercise.

Authors:  A Leal-Cerro; A Gippini; M J Amaya; M Lage; J A Mato; C Dieguez; F F Casanueva
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

Review 7.  [The role of glucose and insulin in the metabolic regulation of growth hormone secretion].

Authors:  E L Sorkina; V V Chichkova; I A Sklyanik; M V Shestakova; G A Mel'nichenko; A Barkan
Journal:  Probl Endokrinol (Mosk)       Date:  2021-01-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.